The global animal model market is poised to experience robust growth, with projected revenue of USD 1,943.3 million in 2024 and a forecasted valuation of USD 3,476.8 million by 2034. Driven by a steady 6% compound annual growth rate (CAGR), this expansion reflects the growing reliance on animal models for research and development in pharmaceuticals, biotechnology, and academic institutions.
Driving Forces: Biological Relevance and Research Efficiency
Animal models play an essential role in preclinical studies due to their shorter life cycles, high genotype resemblance to humans, and adaptability to laboratory testing. These attributes make them indispensable for studying diseases, drug development, and toxicology. Furthermore, increasing investment in biomedical research and the rising prevalence of chronic and infectious diseases are fueling demand for animal models across the globe.
Global Industry Trends and Investments
The report highlights a surge in research initiatives aimed at understanding human diseases and developing novel therapies. Additionally, advancements in genetic engineering technologies, such as CRISPR, have enhanced the precision and relevance of animal models. As a result, key industry players are focusing on innovation and strategic collaborations to capitalize on the growing opportunities in this market.
A Comprehensive Full Report – https://www.futuremarketinsights.com/reports/animal-model-market
Key Takeaways
- The animal model market is set to grow at a CAGR of 6% from 2024 to 2034.
- Market revenue is estimated at USD 1,943.3 million in 2024, reaching USD 3,476.8 million by 2034.
- Short life cycles, genetic similarity to humans, and laboratory adaptability drive the adoption of animal models.
- Growth is supported by rising biomedical research investments and advancements in genetic engineering technologies.
The animal model market is poised to play a crucial role in advancing biomedical research and therapeutic innovation, underscoring its importance in shaping the future of global healthcare solutions.
Growth Drivers
- Increasing Incidence of Chronic Diseases: The rising prevalence of chronic diseases such as cancer, diabetes, and neurological disorders necessitates the use of animal models for research and drug development, driving market demand.
- Advancements in Genetic Engineering: Innovations in genetic engineering techniques, such as CRISPR and transgenic models, enhance the capability of animal models to mimic human diseases more accurately, facilitating better research outcomes.
- Growing Demand for Preclinical Research: The pharmaceutical and biotechnology industries are increasingly relying on animal models for preclinical testing of new drugs and therapies, further fueling market growth.
- Supportive Government Policies and Funding: Increased government funding for biomedical research and supportive regulations regarding animal research contribute to the expansion of the animal model market.
- Rising Awareness of Animal Models in Research: Greater recognition of the importance of animal models in understanding human diseases and developing effective treatments has led to increased investment in this area.
- Technological Innovations in Animal Care and Management: Advances in animal care practices and management technologies improve the welfare and quality of life for laboratory animals, making them more suitable for research purposes.
Regional Insights
- North America is expected to dominate the market due to a high concentration of pharmaceutical companies and a robust research infrastructure.
- The Asia-Pacific region is anticipated to experience significant growth, driven by increasing investments in healthcare research and a growing number of preclinical studies.
Competitive Landscape
Key animal model system providers are focusing on strategic acquisitions, mergers, collaborations, and partnerships to grow their client base and boost their industrial position. Recent investments by leading companies have created prospects for the market to expand globally.
The market is now highly influenced by technological interventions in software modeling for time and cost efficiency, along with the growing ethical concerns in reducing the number of live animals used for research. Recent key developments in the market include the development of a novel monkey research model using CRISPR technology.
Recent Developments in the Global Animal Model Market
In January 2020, Horizon Discovery Group plc. confirmed a partnership and license deal with Mammoth Biosciences to gain access to Mammoth’s unique CRISPR technology. The partnership is expected to make it easier for Horizon to provide a new generation of genetically altered CHO cells to manufacture biotherapeutics such as therapeutic antibodies.
In March 2022, Charles River Laboratories and Hera Biolabs inked a contract for the breeding, marketing, and sales of SRG rats to the world’s preclinical research community. Through this deliberate partnership, Hera BioLabs is aiming to expand the geographic reach of its highly immunodeficient rat model.
Key Players Profiled in the Animal Model Market Report
- Charles River Laboratories International, Inc.
- Horizon Discovery Group plc.
- The Jackson Laboratory
- Taconic Biosciences, Inc.
- Genoway SA
- Eurofins Scientific SE
- Crown Bioscience, Inc.
- Envigo CRS SA
- Transposagen Biopharmaceuticals, Inc.
Key Segments Covered by Animal Model Industry Survey Report
By Species Type:
- Rats
- Mice
- Guinea Pigs
- Rabbits
- Monkeys
- Dogs
- Pigs
- Cats
- Other Species
By Application:
- Basic and Applied Research
- Drug Discovery and Development
- Other Applications
By End User:
- Academic & Research Institutions
- Pharmaceutical Companies
- Biotechnology Companies
- Contract Research Organizations (CROs)
- Other End Users
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia and Pacific
- Middle East and Africa (MEA)
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube